Clinical Trial Results:
A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the efficacy, safety, and tolerability of macitentan in patients with idiopathic pulmonary fibrosis
Summary
|
|
EudraCT number |
2008-006054-17 |
Trial protocol |
DE FR ES SI SE IT |
Global completion date |
30 Jun 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Dec 2016
|
First version publication date |
25 Dec 2016
|
Other versions |
|
Summary report(s) |
AC-055B201-CT.GOV results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.